SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a trending topic following its latest financial results, which indicated pressure on gross margins and a decline in sales within the crucial China market, leading to a divided investor sentiment. The community is actively debating whether current valuations present a 'buy the dip' opportunity for the iconic brand or if intensifying competition and strategic challenges signal a prolonged period of underperformance.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to recent analyst upgrades and widespread discussion surrounding its significant advancements in autonomy and software, including expanding hands-free driving capabilities and plans for in-house AI chips. The community is buzzing with optimism, drawing comparisons to past EV growth trajectories and highlighting the company's long-term potential in the evolving electric vehicle and self-driving technology landscape. This has spurred expectations for continued institutional interest and a potential short squeeze, further amplified by anticipation for its upcoming R2 vehicle.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber (WYFI) is trending after announcing a substantial 10-year, $865 million colocation agreement with Nscale for its NC-1 AI data center campus. The community is buzzing with bullish sentiment, viewing this as a significant step in providing critical AI-ready infrastructure and anticipating substantial stock appreciation amidst high sector demand. This deal is widely seen as a major catalyst, improving revenue visibility and fueling discussions of potential short squeezes.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as recent accolades for its Air sedan and Gravity SUV, including being named to Car and Driver's "10Best" list, offer a glimmer of optimism for some investors. However, a significant portion of the community expresses deep frustration over persistent stock underperformance, comparing it unfavorably to competitors like Rivian, and highlighting concerns about management and the ongoing search for a permanent CEO. The stock's perceived undervaluation due to its advanced technology and strong backing from the Saudi PIF is a central theme amidst continued price volatility.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as the community eagerly anticipates potential federal cannabis rescheduling to Schedule III, a move widely expected to eliminate the burdensome 280E tax and unlock significant profitability for U.S. multi-state operators. Despite market volatility and some "sell the news" reactions, sentiment remains highly bullish, with investors highlighting GTBIF's strong fundamentals and growing presence in the cannabis beverage market as key drivers poised to attract institutional capital.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors hotly debate a lawsuit filed against alleged manipulators, with strong opinions on whether management is effectively addressing stock undervaluation through promised buybacks. The community discussion also centers on the phased rollout of a large AI data center contract and a recent Nobel Sustainability Trust nomination, as many question market integrity and management's actions amidst persistent share price pressure.

PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland.

PDD Holdings Inc - ADR

Pinduoduo Inc.

Pinduoduo is trending following its latest earnings insights, which showed stronger profitability but also highlighted concerns around moderated revenue growth and intensifying market competition. Community discussions reveal a strong underlying bullish sentiment, with many investors anticipating continued upside driven by global e-commerce expansion through Temu, despite the tempered outlook. This creates a fascinating divergence in perception, with significant options activity suggesting expectations for substantial price action.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is a hot topic following its significant strategic pivot, securing substantial funding to transition its business toward an AI-first blockchain and crypto treasury strategy. The community is buzzing, anticipating a rapid upward move given the company's low float and perceived undervaluation after this transformative rebrand to ZeroStack. While many view this as a high-growth opportunity leveraging advanced AI technology, others remain cautious about the rapid shift.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

Molina Healthcare is trending following a significant earnings miss and a reduced profit outlook, primarily attributed to unexpectedly high medical and administrative costs within its Affordable Care Act (ACA) marketplace segment. This financial pressure is intensified by ongoing uncertainty and conflicting reports surrounding the extension of crucial ACA subsidies, a key concern for the entire healthcare insurance sector. Community sentiment is sharply divided, with some viewing the sharp price decline as an attractive buying opportunity while others remain cautious given the complex regulatory environment.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending amid sharp debate following a significant decline, with many investors perceiving it as deeply undervalued given its critical role in AI infrastructure and strong revenue projections. The community is discussing whether the current price reflects a compelling buying opportunity fueled by relentless AI server demand or if persistent concerns over past performance, margin pressures, and broader sector caution will lead to further downside, despite high institutional interest and oversold technicals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 6.3% - Time to Buy?

ARS Pharmaceuticals (NASDAQ:SPRY) Trading 6.3% Higher - What's Next...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the stock...

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1% - Here's What Happened

ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 8.1% - What's Next...

Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY

Franklin Resources Inc. trimmed its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 1.5% during the second quarter, according to the company in its most recent disclosure...

ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research

Zacks Research upgraded shares of ARS Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...

ARS Pharmaceuticals (NASDAQ:SPRY) Trading Up 12.6% - Here's What Happened

ARS Pharmaceuticals (NASDAQ:SPRY) Trading Up 12.6% - Still a Buy...

ARS Pharmaceuticals (NASDAQ:SPRY) Sets New 1-Year Low After Insider Selling

ARS Pharmaceuticals (NASDAQ:SPRY) Hits New 1-Year Low After Insider Selling...

ARS Pharmaceuticals (NASDAQ:SPRY) COO Brian Dorsey Sells 21,828 Shares

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) COO Brian Dorsey sold 21,828 shares of the business's stock in a transaction that occurred on Thursday, November 13th. The shares were sold...

Insider Selling: ARS Pharmaceuticals (NASDAQ:SPRY) Insider Sells 166,380 Shares of Stock

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) insider Justin Chakma sold 166,380 shares of ARS Pharmaceuticals stock in a transaction dated Wednesday, November 12th. The shares were sold...

ARS Pharmaceuticals (NASDAQ:SPRY) Insider Justin Chakma Sells 166,380 Shares

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) insider Justin Chakma sold 166,380 shares of the company's stock in a transaction on Wednesday, November 12th. The stock was sold at an...

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

SPRY
ARS Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SPRY News

SPRYARS Pharmaceuticals Inc